1. National Recommendations on the Diagnosis and Treatment of Chronic Heart Failure (Approved by the Congress of Cardiologists of the Russian Federation in October 2003), Serd. Nedost., 2003, vol. 4, no. 6(22), pp. 276–297.
2. Ageev, F.T., Mareev, V.Yu., Seredenina, E.M., and Belenkov, Yu.N., Prospects of the Introduction of Specialized Forms of Active Outpatient Treatment of Heart Failure: Structure, Methods, and Preliminary Results of the Russian National Program “Chance,” Serd. Nedost., 2004, vol. 5, no. 6(28), pp. 268–271.
3. Belenkov, Yu.N., Mareev, V.Yu., and Ageev, F.T., Initial Results of the National Epidemiological Study on Epidemiological Examination of the Patients with Heart Failure in Real Practice (Based on the Frequency of Visits to Clinics): EPOKhA-O-KhSN, Serd. Nedost., 2003, vol. 4, no. 3, pp. 116–120.
4. Marian, A.J., Genetic Markers: Genes Involved in Human Hypertension, J. Cardiovasc. Risk, 1997, vol. 4, no. 5, pp. 341–345.
5. Soubrier, F., Alhenc-Gelas, F., Hubert, C., et al., Two Putative Active Centers in Human Angiotensin I-Converting Enzyme Revealed by Molecular Cloning, Proc. Natl. Acad. Sci. USA, 1988, vol. 85, no. 24, pp. 9386–9390.